Literature DB >> 4699993

Carbon-13 nuclear magnetic resonance spectroscopy of oxytocin, related oligopeptides, and selected analogs.

A I Brewster, V J Hruby, A F Spatola, F A Bovey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4699993     DOI: 10.1021/bi00732a028

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  6 in total

1.  Conformational studies on arginine vasopressin and arginine vasotocin by proton magnetic resonance spectroscopy.

Authors:  R Walter; A Ballardin; I L Schwartz; W A Gibbons; H R Wyssbrod
Journal:  Proc Natl Acad Sci U S A       Date:  1974-11       Impact factor: 11.205

2.  Carbon-13 magnetic resonance evaluation of polypeptide secondary structure and correlation with proton magnetic resonance studies.

Authors:  D W Urry; L W Mitchell; T Onishi
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

3.  300-MHz nuclear magnetic resonance study of oxytocin aqueous solution: conformational implications.

Authors:  A I Brewster; V J Hruby
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

4.  Conformational studies of oxytocin, lysine vasopressin, arginine vasopressin, and arginine vasotocin by carbon-13 nuclear magnetic resonance spectroscopy.

Authors:  R Walter; K U Prasad; R Deslauriers; I C Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

5.  Oxytocin solution structure changes upon protonation of the N-terminus in dimethyl sulfoxide.

Authors:  T Kato; S Endo; T Fujiwara; K Nagayama
Journal:  J Biomol NMR       Date:  1993-11       Impact factor: 2.835

6.  Arginine-, D-arginine-vasopressin, and their inverso analogues in micellar and liposomic models of cell membrane: CD, NMR, and molecular dynamics studies.

Authors:  Emilia A Lubecka; Emilia Sikorska; Dariusz Sobolewski; Adam Prahl; Jiřina Slaninová; Jerzy Ciarkowski
Journal:  Eur Biophys J       Date:  2015-08-20       Impact factor: 1.733

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.